1-4 of 4
circulating tumor dna
Close
Sort by
Journal Articles

The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA

Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, Olivier Gheysens, Luc Dehaspe, Thomas Tousseyn, Luc-Matthieu Fornecker, Julien Lazarovici, René-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Kamal Bouabdallah, Christiane Copie-Bergman, Bettina Fabiani, Daan Dierickx, Lukas Marcelis, Joris Vermeesch, Marc André, Peter Vandenberghe
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1991–2002.
https://doi.org/10.1182/bloodadvances.2020003039
Published: 2021
Includes: Supplemental data
Journal Articles

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Christopher K. Rushton, Sarah E. Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, Nicole Thomas, Laura K. Hilton, Neil Michaud, Scott Daigle, Jordan Davidson, Kevin Bushell, Stephen Yu, Ryan N. Rys, Michael Jain, Lois Shepherd, Marco A. Marra, John Kuruvilla, Michael Crump, Koren Mann, Sarit Assouline, Joseph M. Connors, Christian Steidl, Mark S. Cragg, David W. Scott, Nathalie A. Johnson, Ryan D. Morin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2886–2898.
https://doi.org/10.1182/bloodadvances.2020001696
Published: 2020
Includes: Supplemental data
Journal Articles

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow

Clinical Trials & Observations
Céline Mazzotti, Laure Buisson, Sabrina Maheo, Aurore Perrot, Marie-Lorraine Chretien, Xavier Leleu, Cyrille Hulin, Salomon Manier, Benjamin Hébraud, Murielle Roussel, Laura Do Souto, Michel Attal, Hervé Avet-Loiseau, Jill Corre
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2811–2813.
https://doi.org/10.1182/bloodadvances.2018025197
Published: 2018
Includes: Supplemental data
Journal Articles

Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition

Clinical Trials & Observations
Gil Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2156–2158.
https://doi.org/10.1182/bloodadvances.2018021782
Published: 2018